Fonseca Lidia 4
4 · PFIZER INC · Filed Mar 3, 2025
Insider Transaction Report
Form 4
PFIZER INCPFE
Fonseca Lidia
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2025-02-27$31.31/sh+72,629$2,274,014→ 111,534 total - Tax Payment
Common Stock
2025-02-27$26.06/sh−68,022$1,772,653→ 41,829 total - Tax Payment
Common Stock
2025-02-27$26.10/sh−1,683$43,926→ 109,851 total - Exercise/Conversion
Stock Appreciation Rights
2025-02-27$31.31/sh−72,629$2,274,014→ 0 totalExercise: $31.31From: 2025-02-27Exp: 2025-02-27→ Common Stock (72,629 underlying)
Footnotes (4)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.